MOSCOW (Reuters) – Russia plans to register a coronavirus vaccine developed by the Vector Research Center by October 15, Rospotrebnadzor reported on Tuesday.
After registration of the vaccine, called “EpiVacCorona”, in October 2020, it is planned to conduct clinical trials involving volunteers over 60 years old and with chronic diseases, as well as post-marketing clinical trials involving 5,000 adult volunteers of different ages, the report said.
The vaccine of the state institute Vector may become the second registered Russian vaccine against coronavirus. In August, the Sputnik V vaccine produced by the N.N. N.F. Gamaleya received a registration certificate from the Russian Ministry of Health, becoming the first registered coronavirus vaccine in the world.
(Gleb Stolyarov. Edited by Anastasia Teterevleva)